ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis - Quartier, P; Baptiste, A; Despert, V (Ann Rheum Dis, 2018)